4-[(1S)-1-Aminoethyl]phenol hydrobromide, 97.0%, 10g

2-oxo-2H-pyran-6-carboxylic acid, 95.0%, 2.5g

(R)-benzyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate, 98%, 10g

2-Ethynyl-1,3-benzothiazole, 97%, 200mg

Infinity corrected plan phase S40x/0.65 objective. Working distance 0.36 mm

(S)-4-(4-Hydroxybenzyl)oxazolidine-2,5-dione, 95.0%, 10g

5-Bromo-2-methyl-4-(trifluoromethyl)pyrimidine, 95.0%, 250mg

3,4-Difluorophenylglyoxal hydrate, 98.0%, 5g

1-(2-(Chloromethyl)phenyl)-1H-1,2,4-triazole, 95.0%, 100mg

(1-Aminocyclopentyl)methanol hydrochloride, 95+%, 5g

2-Chloro-6-iodo-quinoline, 97.0%, 100mg

4-(2-Hydroxyethyl)phenyl methanesulfonate, 97%, 1g

2-(7-Chloro-1H-indol-3-yl)acetic acid, 95.0%, 1g